In the case of suspected bacterial LRTI, a calculated antibiotic therapy with an aminopenicillin plus a beta-lactamase inhibitor should be given, and in patients with known chronic lung disease and patients with tracheostomy and frequently recurring LRTI, piperacillin/tazobactam is considered the drug of choice. This evidence concerns the gene LACTB and chronic lung disease.